MedPath

Effect of Phytosterol and Inulin Fortified Soy Milk on Serum Lipid in Thai-Hypercholesterolemic Volunteers: A Double-Blinded Randomized-Controlled Trial

Phase 2
Completed
Conditions
DL cholesterol
LDL cholesterol&#44
LDL reduction&#44
phytosterol&#44
inulin
Registration Number
TCTR20160921002
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
240
Inclusion Criteria

1) more than 18 years of age
2) had LDL-c of 130-190 mg/dL without lipid lowering medication
3) consent to join the study

Exclusion Criteria

1) LDL-c of >190 mg/dL
2) high risk for cardiovascular disease as determined by Framingham risk assessment of >20% in 10 years
3) LDL-c of >160 mg/dL with risk of >10% in 10 years without receiving lipid lowering medication
4) coronary heart disease, symptomatic carotid artery disease, abdominal aortic aneurysm, or peripheral arterial disease
5) type 1 or type 2 diabetes with hemoglobin A1c (HbA1c) of >7.5%
6) secondary dyslipidemia from nephrotic syndrome, hypothyroidism, hepatic disorder, Cushing’s syndrome, or other conditions
7) malabsorption
8) allergy to soy or soy product

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DL cholesterol 2, 4, 8, 12 weeks lipid profile
Secondary Outcome Measures
NameTimeMethod
total cholesterol, HDL cholesterol, triglyceride 2, 4, 8, 12 weeks lipid profile
© Copyright 2025. All Rights Reserved by MedPath